Lin, Yue
Belue, Mason J.
Yilmaz, Enis C.
Law, Yan Mee
Merriman, Katie M.
Phelps, Tim E.
Gelikman, David G.
Ozyoruk, Kutsev B.
Lay, Nathan S.
Merino, Maria J.
Wood, Bradford J.
Gurram, Sandeep
Choyke, Peter L.
Harmon, Stephanie A.
Pinto, Peter A.
Turkbey, Baris http://orcid.org/0000-0003-0853-6494
Funding for this research was provided by:
National Cancer Institute
Article History
Received: 18 April 2024
Accepted: 19 June 2024
First Online: 3 July 2024
Declarations
:
: Bradford J. Wood: Principal investigator on cooperative research and development agreement (CRADA) between National Institutes of Health (NIH) and Philips and CRADAs with industry partners unrelated to this work; travel support related to CRADAs; royalties from NIH related to Philips licensing agreement; patents planned, issued, or pending. Peter L. Choyke: Receives payment from royalties paid to the U.S. government for patents on MRI US fusion biopsy licensed to Philips Medical. Peter A. Pinto: Institutional CRADA with Philips; royalties from NIH related to Philips licensing agreement; NIH-related patents planned, issued, or pending (U.S. patent nos. 8 447 384 and 10 215 830). Baris Turkbey: CRADAs with NVIDIA and Philips; royalties from NIH; patents planned, issued, or pending in the field of artificial intelligence.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: All coauthors are aware of submission of this work, and they approved the submission.